Memorial Sloan Kettering Cancer Center
New York, 10065, United States
NCT Number: NCT03674437
The purpose of this study is to measure changes in cognitive (mental) function in cancer survivors using a brief, reliable, game-like set of tests that can be completed outside the clinic, as an alternative to traditional neurocognitive assessments. This set of computerized tests, the Cogsuite Assessment, is expected to improve our ability to identify cognitive impairments in people who have been treated for cancer, so that we can (1) learn more about which cognitive functions are affected by cancer treatment, and (2) guide that treatment more effectively.
This study is active but is not currently recruiting participants.
Notify Me40 year–65 year
Female
Observational
New York, 10065, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For All Participants:
For Patients:
For Healthy Controls:
For Healthy 21-25 year old Group:
Exclusion criteria
For All Participants:
For Patients only:
For all remote administrations:
Traditional Neurocognitive Assessments given with pen and paper
Cognition (Cogsuite) for a battery that consists of seven measurements.
Time frame: 2 years
These will include 14 correlations, across the two cohorts and 7 tests (Modified Attention Network Test, N-Back Test, Stop-signal Test, Mental Rotation Test, Verbal Fluency Test, Motor Function Test, and Processing Speed Test).
Memorial Sloan Kettering Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04883398
Breast Cancer Survivors, Memory Disorders
New York, United States
View Trial DetailsNCT06073717
Behavior, Breast Cancer Survivors
Seville, Sevilla, Spain
View Trial DetailsNCT02726763
Breast Cancer Survivors
New York, United States
View Trial DetailsNCT02122107
Breast Cancer Survivors
Duarte, California, United States
View Trial Details